Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma ...Middle East

PR Newswire - News
LUND, Sweden, March 3, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (NASDAQ Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Matthew Shaulis will join the company effective 16 March as Chief Commercial Officer and President of the U....

Hence then, the article about matthew shaulis appointed chief commercial officer and us president of hansa biopharma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News